Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?

During the coronavirus disease 2019 (COVID-19) pandemic, mass vaccination was a beneficial strategy in many countries. Nevertheless, reports of serious complications such as postvaccination neuromyelitis optica spectrum disorder (NMOSD) raised concerns about the safety of vaccines. Anamnart and coll...

Descripción completa

Detalles Bibliográficos
Autores principales: Motahharynia, Ali, Naghavi, Saba, Shaygannejad, Vahid, Adibi, Iman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254455/
https://www.ncbi.nlm.nih.gov/pubmed/35858498
http://dx.doi.org/10.1016/j.msard.2022.104035
_version_ 1784740703429984256
author Motahharynia, Ali
Naghavi, Saba
Shaygannejad, Vahid
Adibi, Iman
author_facet Motahharynia, Ali
Naghavi, Saba
Shaygannejad, Vahid
Adibi, Iman
author_sort Motahharynia, Ali
collection PubMed
description During the coronavirus disease 2019 (COVID-19) pandemic, mass vaccination was a beneficial strategy in many countries. Nevertheless, reports of serious complications such as postvaccination neuromyelitis optica spectrum disorder (NMOSD) raised concerns about the safety of vaccines. Anamnart and colleagues explained postvaccination NMOSD following different vaccines, including COVID-19. To emphasize the message of this article, in this letter, we present a unique case of postvaccination NMOSD with a fulminant and fatal course, which may show a plausible relationship between COVID-19 vaccination and triggering anti-aquaporin-4 antibody (AQP4-Ab).
format Online
Article
Text
id pubmed-9254455
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-92544552022-07-05 Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration? Motahharynia, Ali Naghavi, Saba Shaygannejad, Vahid Adibi, Iman Mult Scler Relat Disord Correspondence During the coronavirus disease 2019 (COVID-19) pandemic, mass vaccination was a beneficial strategy in many countries. Nevertheless, reports of serious complications such as postvaccination neuromyelitis optica spectrum disorder (NMOSD) raised concerns about the safety of vaccines. Anamnart and colleagues explained postvaccination NMOSD following different vaccines, including COVID-19. To emphasize the message of this article, in this letter, we present a unique case of postvaccination NMOSD with a fulminant and fatal course, which may show a plausible relationship between COVID-19 vaccination and triggering anti-aquaporin-4 antibody (AQP4-Ab). Elsevier B.V. 2022-10 2022-07-05 /pmc/articles/PMC9254455/ /pubmed/35858498 http://dx.doi.org/10.1016/j.msard.2022.104035 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Motahharynia, Ali
Naghavi, Saba
Shaygannejad, Vahid
Adibi, Iman
Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?
title Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?
title_full Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?
title_fullStr Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?
title_full_unstemmed Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?
title_short Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?
title_sort fulminant neuromyelitis optica spectrum disorder (nmosd) following covid-19 vaccination: a need for reconsideration?
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254455/
https://www.ncbi.nlm.nih.gov/pubmed/35858498
http://dx.doi.org/10.1016/j.msard.2022.104035
work_keys_str_mv AT motahharyniaali fulminantneuromyelitisopticaspectrumdisordernmosdfollowingcovid19vaccinationaneedforreconsideration
AT naghavisaba fulminantneuromyelitisopticaspectrumdisordernmosdfollowingcovid19vaccinationaneedforreconsideration
AT shaygannejadvahid fulminantneuromyelitisopticaspectrumdisordernmosdfollowingcovid19vaccinationaneedforreconsideration
AT adibiiman fulminantneuromyelitisopticaspectrumdisordernmosdfollowingcovid19vaccinationaneedforreconsideration

Ejemplares similares